Experimental Drug Takes on Injury From Fatty Liver Experimental Drug Takes on Injury From Fatty Liver

An investigative human fibroblast growth factor 19 analog is in development to reduce markers of liver damage in patients with nonalcoholic steatohepatitis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news